Int. J. Biosci.12(3), 224-234, March 2018
The thalassemia is a common etiological, microcytic and hypochromic anemia. It is an autosomal genetic disorder caused by mutations in α and β globin genes. In this experiment, hematological study conducted among the β-thalassemia major patients selected from urban (n=20) and rural (n=20) areas of Hyderabad. Patients from both regions were arranged into two age-groups (group I=2-7 years and group II= 5-11 years). Each group comprised on 10 males and 10 females (half rural and half city) in total 20 of confirmed β-thalassemia major patients. With hematological analysis showed significant variation, like as lowest red blood cells (RBCs) measured in male patients of both groups from urban and rural patients than all females. The hemoglobin (HB), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCH), mean corpuscular hemoglobin concentration (MCHC) and platelets (PLT) showed variable (p≥0.05) abnormal values in all patients over normal reference values. The Hb also observed as reduced in all patients especially in 5-11 years aged male patients (p≥0.05). Meanwhile total iron contents and iron binding capacity (TIBC) noted reversed to Hb contents in all β-thalassemia major. In conclusion, rises in hematological parameters and iron overload causes to enhance antioxidant activity (AOA). The AOA may be beneficial for lowering the stringency of developed oxidative stress due to iron overload. It could be dependent on the type of AOA as well as their sources. Growth failure is common in thalassemia patients, while it is achievable with blood transfusion and optimal balanced nutritional status.
Adel AH, Mohamed AE, Enaam SAE. 2015. Original article assessment of t lymphocyte subsets in children with beta thalassemia major with iron overload correspondence. Egyptian Society of Pediatric Allergy and Immunology 13(2), 57-63.
Al-Buhairan AM, Oluboyede OA. 2001. Determination of serum iron, total iron-binding capacity and serum ferritin in healthy saudi adults. Annals of Saudi Medicine 21(1–2), 100-103.
Baig SM, Din MA, Hassan H, Azhar A, Baig JM, Aslam M, Anjum I, Farooq M, Hussain MS, Rasool M, Nawaz S, Qureshi JA, Zaman T. 2008. Prevention of β-thalassemia in a large Pakistani family through cascade testing. Community Genetics 11(1), 68-70.
Baig SM, Kiyani A, Hameed U, Rabbi F, Bokhari H, Aslam M, Din MAU, Baig SA, Hassan K, Qureshi JA, Zaman T. 2006. Spectrum of beta-thalassemia mutations in various regions of Punjab and Islamabad, Pakistan: Establishment of Prenatal Diagnosis. Haematology 91(3), 91-93.
Baldini M, Forti S, Marcon A, Ulivieri FM, Orsatti A, Tampieri. B, Airaghi L, Zanaboni L, Cappellini MD. 2010. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major. Annals of Hematology 89(12), 1207-1213.
Bank A. 2005. Understanding globin regulation in β-thalassemia: it’s as simple as α, β, γ, δ. Journal of Clinical Investigation 115(6), 1470-1473.
Behrens JT. 1997. Principles and Procedures of Exploratory Data Analysis. Psychological Methods 2(2), 131-160. http://doi.apa.org/getdoi.cfm?doi= 10.1037/1082-989X.2.2.131.
Benetou VC, Bamia DT, and Trichopoulou A. 2006. Associations of anthropometric characteristics with blood cholesterol fractions among adults. the greek EPIC study. European Journal of Clinical Nutrition 60(8), 942-948.
Blair HC, Carrington JL. 2006. Bone cell precursors and the pathophysiology of bone loss. Annals of the New York Academy of Sciences 1068, 244-249.
Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A. 2004. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematology 89(10), 1187-1193.
Cao A, Renzo G. 2010. Beta-thalassemia. BMC Medical Genetics 12(2), 61-76.
Carmina E, Sioundas A, Karatzas N, Aggellaki M, Pazaitou K, Vainas I. 2004. Hypogonadism and hormone replacement therapy on bone mass of adult women with thalassemia major. Calcified Tissue International 74(1), 68-71.
Casale M, Citarella S, Filosa A, Michele ED, Palmieri F, Ragozzino A, Amendola G, Pugliese U, Tartaglione I, Rocca FD, Cinque P, Nobili B, Perrotta S. 2014. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. American journal of hematology 89(12), 1102-1106.
De Sanctis V, Soliman AT, Elsedfy H, Skordis N, Kattamis C, Angastiniotis M, Karimi, M, Yassin MAD, Mohd EAA, Stoeva, IR, Giuseppe G, Maria CB, Elsaid MF, Fiscina BKM. 2013. Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines. Indian Journal of Endocrinology and Metabolism 17(1), 8-18. www.ijem.in/ text.asp?2013/17/1/8/107808.
Eldin I, Hussein E, Mohammed MA. 2016. Determination of iron content in different hemoglobin samples from some patients by UV-visible spectrophotometer. Advances in Analytical Chemistry 6(2), 35-40.
Eshghi P, Alavi S, Ghavami S, Rashidi A. 2007. Growth impairment in beta-thalassemia major: The role of trace element deficiency and other potential factors. Journal of Pediatric Hematology/Oncology 29(1), 5-8.
Evenson MA, Carmack GD. 1979. Clinical chemistry. Journal of Analytical Chemistry 51(5), 35-79.
Farashi SB, Garous NF, Ashki N, Niat MM, Vakili M, Imanian S, Zeinali H, Najmabadi S, Azita HA. 2015. Interaction of an α-globin gene triplication with β-globin gene mutations in Iranian patients with β-thalassemia intermedia. Hemoglobin 39(3), 201-206.
Feldman BF, Keen CL, Kaneko JJ, Farver TB. 1981. Anemia of inflammatory disease in the dog: Measurement of hepatic superoxide dismutase, hepatic nonheme iron, copper, zinc, and ceruloplasmin and serum iron, copper, and zinc. American Journal of Veterinary Research 42(7), 1114-1117.
Flint J, Harding RM, Boyce AJ, Clegg JB. 1998. The population genetics of the haemoglobinopathies. Baillieres Clinical Haematology 11(1), 1-51.
Fucharoen S, Pranee W. 1992. Review thalassemia in southeast asia: problems and strategy for prevention and control. Southeast Asian Journal of Tropical Medicine and Public Health 23(4), 647-55.
Harthoorn-Lasthuizen EJ, Lindemans J, Langenhuijsen MM. 1999. Influence of iron deficiency anaemia on haemoglobin A2 levels: Possible consequences for beta-thalassaemia screening. Scandinavian Journal of Clinical and Laboratory Investigation 59(1), 65-70. www. ncbi.nlm.nih.gov/pubmed/10206099.
Helley D, Eldor A, Girot R, Ducrocq R, Guillin MC, Bezeaud A. 1996. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia. Thrombosis and Haemostasis 76(3), 322-327. www.ncbi.nlm.nih.gov/pubmed/8883264.
Henley S. 1983. Computers and geosciences; Principles and procedure of statistics: A Biometrical Approach 3,136-145.
Hoffbrand AV, Ali T, Maria DC. 2012. How i treat transfusional iron overload. Blood 120(18), 3657-3669.
Ishaq F, Abid H, Kokab F, Akhtar A, Mahmood S. 2012. Awareness among parents of β-thalassemia major patients, regarding prenatal diagnosis and premarital screening. Journal of College of Physicians and Surgeons Pakistan 22(4), 218-221.
Jacobs G, Calvert C, Kraus M. 2000. Hepatopathy in 4 dogs treated with amiodarone. Journal of Veterinary Internal Medicine 14(1), 96-99.
Javed AM, Sumble. 2013. Predictors of caregivers burden:interplay of physical and emotional health and percieved hope in children with thalassemia and hemophilia. Pakistan Journal of Professional Psychology 11(2), 36-42.
Jeffreys AJ, Wilson V, Wood D, Kay RM, Williams JG. 1980. Linkage of adult α- and β-globin genes in X. laevis and gene duplication by tetraploidization. Cell 21(2), 555-564.
Karim F, Ismail M, Hasan AM, Shekhar HU. 2016. Hematological and biochemical status of betathalassemia major patients in Bangladesh: A comparative analysis. International Journal of Hematology–Oncology and Stem Cell Research 10(1), 224-229.
Kasvosve I, Delanghe J. 2002. Total iron binding capacity and transferrin concentration in the assessment of iron status. Clinical Chemistry and Laboratory Medicine 40(10), 1014-1018.
Korotkova EI, Freinbichler W, Linert W, Elena V. 2013. Study of total antioxidant activity of human serum blood in the pathology of alcoholism. Molecules 18(2), 1811-1818.
La Nasa G, Argiolu F, Giardini C, Pession A, Fagioli F, Caocci G, Vacca A, De Stefano P, Piras E, Ledda A, Piroddi A, Littera R, Nesci S, Locatelli F. 2005. Unrelated bone marrow transplantation for beta-thalassemia patients: the experience of the italian bone marrow transplant group. Annals of the New York Academy of Sciences 1054, 186-195. www.ncbi.nlm.nih.gov/pubmed/16339665.
Lewis SM, Garvey B, Manning R, Sharp SA, Wardle J. 1991. Lauryl sulphate haemoglobin: a non‐hazardous substitute for HiCN in haemoglobinometry. Clinical and Laboratory Haematology 13(3), 279-290.
Lucarelli G, Clift RA, Galimberti M, Angelucci E, Giardini C, Baronciani D, Polchi P, Andreani M, Gaziev D, Erer B, Ciaroni A, D’Adamo F, Albertini F, Muretto P. 1999. Bone marrow transplantation in adult thalassemic patients. Blood 93(4), 1164-1167. www.ncbi.nlm. nih.gov/pubmed/9949158.
Mahyar A, Ayazi P, Pahlevan AA, Mojabi H, Sehhat MR, Javadi A. 2010. Zinc and copper status in children with beta-thalassemia major. Iranian Journal of Pediatrics 20(3), 297-302. www.pubmedcentral.nih.gov/articlerender.-fcgi?artid=PMC3446035.
Merchant RH, Shirodkar A, Javed A. 2011. Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused indian thalassemia patients. Indian Journal of Pediatrics 78(6), 679-683.
Mohseni F, Mohajeri-Tehrani MR, Larijani B, Hamidi Z. 2014. Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients. Archives of Osteoporosis 9, 174.
Moosavian HR, Mohri M, Seifi HA. 2010. Effects of parenteral over-supplementation of vitamin a and iron on hematology, iron biochemistry, weight gain, and health of neonatal dairy calves. Food and Chemical Toxicology 48(5), 1316-1320.
Mosca A, Paleari R, Ivaldi G, Galanello R, Giordano PC. 2009. The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies. Journal of Clinical Pathology 62(1), 13-17.
Muncie HL, Campbell J. 2009. Alpha and beta thalassemia. American Family Physician 80(4), 339-344. www.europepmc.org/abstract/med/19678601%5Cn www.ncbi.nlm.-nih.gov/pubmed/196 78601.
Nosheen A, Inamullah, Ahmad H, Abbasi FM, Din AU, Iqbal MS. 2015. Premarital genetic screening for beta thalassemia carrier status of indexed families using HbA2 electrophoresis. Journal of the Pakistan Medical Association 65(10), 1047-1049.
Nuntakarn L, Fucharoen S, Fucharoen G, Sanchaisuriya K, Jetsrisuparb A, Wiangnon S. 2009. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb β-thalassemia in Northeast Thailand. Blood Cells, Molecules and Diseases 42(1), 32-35.
Origa R, Bina P, Agus A, Crobu G, Defraia E, Dessì C, Leoni G, Muroni PP, Galanello R. 2005. Combined therapy with deferiprone and desferrioxamine in thalassemia major. Haematologica 90(10), 1309-1314.
Ottenjann M, Christiane W, Arndt G, Barbara K. 2006. Characterization of the anemia of inflammatory disease in cats with abscesses, pyothorax, or fat necrosis. Journal of Veterinary Internal Medicine 20(5), 1143-1150.
Piomelli S, Loew T. 1991. Management of thalassemia major (Cooley’s Anemia). Hematology. Oncology Clinics of North America 5(3), 557-569. www.ncbi.nlm.nih.gov/-pubmed/1864823.
Quinn GP, Michael JK. 2002. Experimental design and data analysis for biologists. Experimental Design and Data Analysis for Biologists 3, 121-131.
Roberts WL, Smith PT, Martin WJ, Rainey PM. 1999. Performance characteristics of three serum iron and total iron-binding capacity methods in acute iron overdose. American Journal of Clinical Pathology 112(5), 657-664.
Rocher E, Chappard C, Jaffre C, Benhamou C, Courteix D. 2008. Bone mineral density in prepubertal obese and control children: Relation to body weight, lean mass, and fat mass. Journal of Bone and Mineral Metabolism 26(1), 73-78. http://link.springer.com/10.1007/s00774-007-0786-4.
Rosen CJ, Klibanski A. 2009. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. American Journal of Medicine 122(5), 409-414. http://linkinghub.elsevier.com/retrieve/pii/ S0002934309000503.
Rund D, Rachmilewitz E. 2005. β-thalassemia. New England Journal of Medicine 353, 1135-1146. www.nejm.org/doi/full/10.1056/NEJMra050436.
Shah VB, Shah BS, Puranik GV. 2011. Evaluation of non cyanide methods for hemoglobin estimation. Indian Journal of Pathologists and Microbiologists 54(4), 764-768.
Shishikura F, Kazutoshi T. 2001. The amino acid sequences of the α- and β-globin chains of hemoglobin from the aldabra giant tortoises, geochelone gigantea. Zoological Science 18(4), 515-526.
Smith JE, Cipriano JE. 1987. Inflammation-induced changes in serum iron analytes and ceruloplasmin of shetland ponies. Veterinary Pathology 24(4), 354-356.
Sripichai O, Munkongdee T, Kumkhaek C, Svasti S, Winichagoon P, Fucharoen S. 2008. Coinheritance of the different copy numbers of α-globin gene modifies severity of β-thalassemia/Hb E disease. Annals of Hematology 87(5), 375-379.
Sun Y, Oberley LW, Li Y. 1988. A simple method for clinical assay of superoxide dismutase. Clinical chemistry 34(3), 497-500.
Taher A, Ismaeel H, Cappellini MD. 2006. Thalassemia intermedia: revisited. Blood Cells, Molecules and Diseases 37(1), 12-20.
Toumba M, Sergis A, Kanaris C, Skordis N. 2007. Endocrine complications in patients with thalassaemia major. Pediatric Endocrinology Reviews 5(2), 642-648.
Verma S, Gupta R, Kudesia M, Mathur A, Krishan G, Singh S. 2014. Coexisting iron deficiency anemia and beta thalassemia trait: Effect of iron therapy on red cell parameters and hemoglobin subtypes. ISRN Hematology 2014, 1-5. www.hindawi.com/journals/isrn/2014/293216/.
Vichinsky EP. 2005. Changing patterns of thalassemia worldwide. Annals of the New York Academy of Sciences 1054, 18-24.
Vlychou M, Evangelos A, Paschalis T, Ioannis F, Katerina V. 2016. Body composition in adult patients with thalassemia major. International Journal of Endocrinology 2016, 1-7.
Weatherall D. 2011. The inherited disorders of haemoglobin: an increasingly neglected global health burden. Indian Journal of Medical Research 134(10), 493-497.
Wheeler D, Hope RM, Cooper SJB, Gooley AA, Holland RAB. 2004. Linkage of the β-like ω-globin gene to α-like globin genes in an australian marsupial supports the chromosome duplication model for separation of globin gene clusters. Journal of Molecular Evolution 58(6), 642-652.
White KN, Conesa C, Sanchez L, Amini M, Farnaud S, Lorvoralak C, Evans RW. 2012. The transfer of iron between ceruloplasmin and transferrins. Biochimica et Biophysica Acta 1820(3), 411-416.
Yamanishi H, Iyama S, Yamaguchi Y, Kanakura Y, Iwatani Y. 2003. Total iron-binding capacity calculated from serum transferrin concentration or serum iron concentration and unsaturated iron-binding capacity. Clinical Chemistry 49(1), 175-178.